Out-of-equilibrium electromagnetic radiation

We derive general formulas for photon and dilepton production rates from an arbitrary non-equilibrated medium from first principles in quantum field theory. At lowest order in the electromagnetic coupling constant, these relate the rates to the unequal-time in-medium photon polarization tensor and generalize the corresponding expressions for a system in thermodynamic equilibrium. We formulate the question of electromagnetic radiation in real time as an initial value problem and consistently describe the virtual electromagnetic dressing of the initial state. In the limit of slowly evolving systems, we recover known expressions for the emission rates and work out the first correction to the static formulas in a systematic gradient expansion. Finally, we discuss the possible application of recently developed techniques in non-equilibrium quantum field theory to the problem of electromagnetic radiation. We argue, in particular, that the two-particle-irreducible (2PI) effective action formalism provides a powerful resummation scheme for the description of multiple scattering effects, such as the Landau-Pomeranchuk-Migdal suppression recently discussed in the context of equilibrium QCD.Comment: 34 pages, 9 figures, uses JHEP3.cl

Views of the Chiral Magnetic Effect

My personal views of the Chiral Magnetic Effect are presented, which starts with a story about how we came up with the electric-current formula and continues to unsettled subtleties in the formula. There are desirable features in the formula of the Chiral Magnetic Effect but some considerations would lead us to even more questions than elucidations. The interpretation of the produced current is indeed very non-trivial and it involves a lot of confusions that have not been resolved.Comment: 19 pages, no figure; typos corrected, references significantly updated, to appear in Lect. Notes Phys. "Strongly interacting matter in magnetic fields" (Springer), edited by D. Kharzeev, K. Landsteiner, A. Schmitt, H.-U. Ye

High-­resolution bio-­ and chemostratigraphy of an expanded record of Oceanic Anoxic Event 2 (Late Cenomanian–Early Turonian) at Clot Chevalier, near Barrême, SE France (Vocontian Basin, SE France)

A newly located exposure of the Niveau Thomel, an organic-­‐rich level at the Cenomanian–Turonian boundary, provides a highly expanded record of Oceanic Anoxic Event (OAE) 2, excepted for the lower relatively condensed glauconite-­rich part of the section. The new locality, close to Barrême in the Vocontian Basin, SE France, is developed in deep-­water hemi-­pelagic facies (shales, marls, marly limestones, variably enriched in organic matter) and provides an improved understanding of palaeoceanographic events associated with OAE 2. Investigation of the biostratigraphy (nannofossils and planktonic foramininfera), organic and inorganic geochemistry (bulk carbonate δ18O, total organic carbon (TOC), bulk organic, biomarker-specific and carbonate δ13C, major and trace elements, and Rock-­Eval data) has allowed characterization of the sediments in great detail. The combined study further constrains the detailed relationship between bio-­ and chemostratigraphy (particularly with respect to the details of the well-­displayed positive carbon-­‐isotope excursion) for this interval. The section also provides new evidence, in the form of a positive oxygen-­isotope excursion and an offset between carbonate and organic-­carbon carbon-­isotope records, which confirms the importance of cooling accompanied by a drop in dissolved CO2 in near-­surface waters during the Plenus Cold Event that characterized the early part of OAE 2. Evidence for increased oxygenation of bottom waters, together with elevated concentrations of redox-­sensitive and chalcophilic elements registered elsewhere through the level of the Plenus Cold Event, may be reflected in enhanced concentrations of iron (in glauconite) and nickel in coeval strata from the Clot Chevalier section

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer : long-term survival results from the STAMPEDE trial

Background STAMPEDE has previously reported that the use of upfront docetaxel improved overall survival (OS) for metastatic hormone naïve prostate cancer patients starting long-term androgen deprivation therapy. We report on long-term outcomes stratified by metastatic burden for M1 patients. Methods We randomly allocated patients in 2 : 1 ratio to standard-of-care (SOC; control group) or SOC + docetaxel. Metastatic disease burden was categorised using retrospectively-collected baseline staging scans where available. Analysis used Cox regression models, adjusted for stratification factors, with emphasis on restricted mean survival time where hazards were non-proportional. Results Between 05 October 2005 and 31 March 2013, 1086 M1 patients were randomised to receive SOC (n = 724) or SOC + docetaxel (n = 362). Metastatic burden was assessable for 830/1086 (76%) patients; 362 (44%) had low and 468 (56%) high metastatic burden. Median follow-up was 78.2 months. There were 494 deaths on SOC (41% more than the previous report). There was good evidence of benefit of docetaxel over SOC on OS (HR = 0.81, 95% CI 0.69–0.95, P = 0.009) with no evidence of heterogeneity of docetaxel effect between metastatic burden sub-groups (interaction P = 0.827). Analysis of other outcomes found evidence of benefit for docetaxel over SOC in failure-free survival (HR = 0.66, 95% CI 0.57–0.76, P  0.5 in each case). There was no evidence that docetaxel resulted in late toxicity compared with SOC: after 1 year, G3-5 toxicity was reported for 28% SOC and 27% docetaxel (in patients still on follow-up at 1 year without prior progression). Conclusions The clinically significant benefit in survival for upfront docetaxel persists at longer follow-up, with no evidence that benefit differed by metastatic burden. We advocate that upfront docetaxel is considered for metastatic hormone naïve prostate cancer patients regardless of metastatic burden

CP-rays in simplicial cones

An interior point of a triangle is called CP-point if its orthogonal projection on the line containing each side lies in the relative interior of that side. In classical mathematics, interest in the concept of regularity of a triangle is mainly centered on the property of every interior point of the triangle being a CP-point. We generalize the concept of regularity using this property, and extend this work to simplicial cones in ℝ n , and derive necessary and sufficient conditions for this property to hold in them. These conditions highlight the geometric properties of Z-matrices. We show that these concepts have important ramifications in algorithmic studies of the linear complementarity problem. We relate our results to other well known properties of square matrices.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/47921/1/10107_2005_Article_BF01582265.pd

Chelation in Metal Intoxication

Chelation therapy is the preferred medical treatment for reducing the toxic effects of metals. Chelating agents are capable of binding to toxic metal ions to form complex structures which are easily excreted from the body removing them from intracellular or extracellular spaces. 2,3-Dimercaprol has long been the mainstay of chelation therapy for lead or arsenic poisoning, however its serious side effects have led researchers to develop less toxic analogues. Hydrophilic chelators like meso-2,3-dimercaptosuccinic acid effectively promote renal metal excretion, but their ability to access intracellular metals is weak. Newer strategies to address these drawbacks like combination therapy (use of structurally different chelating agents) or co-administration of antioxidants have been reported recently. In this review we provide an update of the existing chelating agents and the various strategies available for the treatment of heavy metals and metalloid intoxications

Towards a definition of sarcopenia--results from epidemiologic studies

The age-related loss of muscle mass, also called sarcopenia, is receiving increasing attention in aging research. While the concept is frequently being used in research settings and introduced to clinical settings, thus far no consensus on its definition has been established. This article provides an overview of the history of sarcopenia definitions proposed in the literature thus far. It will describe the methodology used to develop the cutpoints for low muscle mass (or strength) in large epidemiological studies, how sarcopenia based on these cutpoints relates to functional outcomes, and the advantages and disadvantages of the different definitions. This overview will contribute to the current need to develop a consensus definition of sarcopenia which can be used in all relevant settings. The Journal of Nutrition, Health & Aging©

Genetic loci influencing kidney function and chronic kidney disease

Using genome-wide association, we identify common variants at 2p12-p13, 6q26, 17q23 and 19q13 associated with serum creatinine, a marker of kidney function (P = 10 10 to 10 15). Of these, rs10206899 (near NAT8, 2p12-p13) and rs4805834 (near SLC7A9, 19q13) were also associated with chronic kidney disease (P = 5.0 × 10 5 and P = 3.6 × 10 4, respectively). Our findings provide insight into metabolic, solute and drug-transport pathways underlying susceptibility to chronic kidney disease